A Rare Complication Following Transarterial Chemoembolization for Hepatocellular Carcinoma

肝動脈化療栓塞治療肝癌的罕見併發症

林煒晟(Wei-Chen Lin) ； 王蒼恩(Tsang-En Wang) ； 王鴻源(Horng-Yang Wang) ； 施壽全(Shou-Chuan Shih)

《台灣癌症醫學雜誌》 2卷4期 (2015/12) Pp. 314-318

https://doi.org/10.6323/JCRP.2015.2.4.6

摘要

根據2013年台灣年度十大死因報告，癌症仍然佔首位，其中肝癌是第二常見的癌症死因。肝動脈化療栓塞已廣泛用於治療不能手術切除的肝癌和提升巴塞隆納肝癌分類為中期患者的存活率。儘管肝動脈化療栓塞併發症不高，嚴重的併發症仍會發生。我們報告一位54歲肝癌患者在做完肝動脈化療栓塞後有嚴重腹痛，之後檢查發現右腎包膜下血腫之罕見併發症。

關鍵字

肝動脈化療栓塞治療 ； 肝細胞癌 ； 併發症

並列摘要

According to the Taiwanese government's official annual report listing the top 10 causes of death, cancer was the leading cause of death in Taiwan in 2013, with hepatocellular carcinoma ranking second among those cancer deaths. Transarterial chemoembolization has been shown to be widely used in the treatment for unresectable disease, and increase survival in patients with intermediate stage hepatocellular carcinoma according to the Barcelona Clinic Liver Cancer classification. Despite relatively low morbidity, however, major complications may be seen. We report the case of a 54-year-old male with hepatocellular carcinoma who suffered from severe abdominal pain after transarterial chemoembolization, where further studies found a rare complication of subcapsular hematoma of the right kidney.

並列關鍵字

hepatic artery chemoembolization ； hepatocellular carcinoma ； complications